Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 123, Issue 11, Pages 1736-1761Publisher
WILEY
DOI: 10.1002/jcb.30173
Keywords
apoptosis; cell mutations; resistance; targeted therapy
Categories
Funding
- Natural Sciences and Engineering Research Council of Canada [1257509]
Ask authors/readers for more resources
The article summarizes the mutations in apoptotic pathways associated with cancer development, as well as the targeted therapies currently available or in trial.
The apoptosis pathway is a programmed cell death mechanism that is crucial for cellular and tissue homeostasis and organ development. There are three major caspase-dependent pathways of apoptosis that ultimately lead to DNA fragmentation. Cancerous cells are known to highly regulate the apoptotic pathway and its role in cancer hallmark acquisition has been discussed over the past decades. Numerous mutations in cancer cell types have been reported to be implicated in chemoresistance and treatment outcome. In this review, we summarize the mutations of the caspase-dependant apoptotic pathways that are the source of cancer development and the targeted therapies currently available or in trial.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available